GlycoMira Therapeutics, Inc.
www.glycomira.comGlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.
Read more
GlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.
Read more
Country
State
Utah
City (Headquarters)
Salt Lake City
Industry
Employees
1-10
Founded
2008
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Research
Email ****** @****.comPhone (***) ****-****Vice President of Operations
Email ****** @****.comPhone (***) ****-****Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****President and Chief Financial Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(12)
Reach decision makers at GlycoMira Therapeutics, Inc.
Free credits every month!
GlycoMira Therapeutics, Inc. FAQ
Salt Lake City, United States
Biotechnology Research
